Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone

References

• LoftssonaTJarvinenTCyclodextrins in ophthalmic drug deliveryAdv Drug Deliv Rev1999361597910837709
   PubMed Web of Science ®Google Scholar
• RibeiroAMFigueirasAVeigaFImprovements in topical ocular drug delivery systems: hydrogels and contact lensesJ Pharm Pharm Sci201518568369526670365
   PubMedGoogle Scholar
• VandammeTFMicroemulsions as ocular drug delivery systems: recent developments and future challengesProg Retin Eye Res2002211153411906809
   PubMed Web of Science ®Google Scholar
• FialhoSLDa Silva-CunhaANew vehicle based on a microemulsion for topical ocular administration of dexamethasoneClin Exp Ophthalmol200432662663215575833
   PubMed Web of Science ®Google Scholar
• KaurIPSmithaRPenetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug deliveryDrug Dev Ind Pharm200228435336912056529
   PubMed Web of Science ®Google Scholar
• ShortBGSafety evaluation of ocular drug delivery formulations: techniques and practical considerationsToxicol Pathol2008361496218337221
   PubMed Web of Science ®Google Scholar
• GuanghanDJunfengBYanZPreparation and suitability evaluation of coumarin-6 nanoprobes for ophthalmic useChin J Pharm20164703305309
   Google Scholar
• JanoriaKGGundaSBodduSHNovel approaches to retinal drug deliveryExpert Opin Drug Deliv20074437138817683251
   PubMed Web of Science ®Google Scholar
• AraújoJNikolicSEgeaMASoutoEBGarciaMLNanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eyeColloids Surf B Biointerfaces201188115015721764568
   PubMed Web of Science ®Google Scholar
• LoftssonTHreinsdottirDStefanssonECyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye dropsJ Pharm Pharmacol200759562963517524227
   PubMed Web of Science ®Google Scholar
• TanitoMHaraKTakaiYTopical dexamethasone-cyclodextrin microparticle eye drops for diabetic macular edemaInvest Ophthalmol Vis Sci201152117944794821896859
   PubMed Web of Science ®Google Scholar
• ChanJMaghrabyGMCraigJPAlanyRGPhase transition water-in- oil microemulsions as ocular drug delivery systems: in vitro and in vivo evaluationInt J Pharm20073281657117092668
   PubMedGoogle Scholar
• BaspinarYBertelmannEPleyerUBuechGSiebenbrodtIBorchertHHCorneal permeation studies of everolimus microemulsionJ Ocul Pharmacol Ther200824439940218665812
   PubMedGoogle Scholar
• RazaKKumarMKumarPTopical delivery of aceclofenac: challenges and promises of novel drug delivery systemsBiomed Res Int2014201440673125045671
   PubMed Web of Science ®Google Scholar
• KumarLVermaSBhardwajAVaidyaSVaidyaBEradication of superficial fungal infections by conventional and novel approaches: a comprehensive reviewArtif Cells Nanomed Biotechnol2014421324623452349
   PubMed Web of Science ®Google Scholar
• SaariKMNelimarkkaLAholaVComparison of topical 0.7% dexamethasone cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammationGraefes Arch Clin Exp Ophthalmol2006244562062616217662
   PubMedGoogle Scholar
• JohannessonGMoya-OrtegaMDAsgrimsdottirGMKinetics of gamma-cyclodextrin nanoparticle suspension eye drops in tear fluidActa Ophthalmol201492655055624373641
   PubMed Web of Science ®Google Scholar
• PalmaSDTartaraLIQuinterosDAllemandiDALonghiMRGraneroGEAn efficient ternary complex of acetazolamide with HP-ss-CD and TEA for topical ocular administrationJ Control Release20091381243119426769
   PubMedGoogle Scholar
• SigurdssonHHKonráethsdóttirFLoftssonTStefánssonETopical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eyeActa Ophthalmol Scand200785659860217645424
   PubMedGoogle Scholar
• BoddupalliBMohammedZKNathRMucoadhesive drug delivery system: an overviewJ Adv Pharm Technol Res20101438122247877
   PubMedGoogle Scholar
• de CamposAMDieboldYCarvalhoELSánchezAAlonsoMJChitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicityPharm Res200421580381015180338
   PubMed Web of Science ®Google Scholar
• QuinterosDAFerreiraLMSchaffazickSRPalmaSDAllemandiDACruzLNovel polymeric nanoparticles intended for ophthalmic administration of acetazolamideJ Pharm Sci2016105103183319027519647
   PubMedGoogle Scholar
• UrttiAChallenges and obstacles of ocular pharmacokinetics and drug deliveryAdv Drug Deliv Rev200658111131113517097758
   PubMed Web of Science ®Google Scholar
• AgrahariVAgrahariVHungWTChristensonLKMitraAKComposite nanoformulation therapeutics for long-term ocular delivery of macromoleculesMol Pharm20161392912292226828415
   PubMed Web of Science ®Google Scholar
• MahlumbaPChoonaraYEKumarPdu ToitLCPillayVStimuli-responsive polymeric systems for controlled protein and peptide delivery: future implications for ocular deliveryMolecules2016218E100227483234
   PubMedGoogle Scholar
• HiraniAGroverALeeYWPathakYSutariyaVTriamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degenerationPharm Dev Technol2016211616725259682
   PubMed Web of Science ®Google Scholar
• You-yunDUJun-FengBYanZPreliminary evaluation of in vitro transportation characteristics of triamcinolone acetonide eye dropsChin Hosp Pharm J201612968972
   Google Scholar
• DesaiJThakkarHEffect of particle size on oral bioavailability of darunavir loaded solid lipid nanoparticlesJ Microencapsul201633766967827701988
   PubMed Web of Science ®Google Scholar
• GhanbarzadehSHaririRKouhsoltaniMShokriJJavadzadehYHamishehkarHEnhanced stability and dermal delivery of hydroquinone using solid lipid nanoparticlesColloids Surf B Biointerfaces20151361004101026579567
   PubMed Web of Science ®Google Scholar
• WangLLiHWangSEnhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulationAAPS Pharm Sci Tech2014154834844
   PubMedGoogle Scholar
• StewartJMLeeOTWongFFSchultzDSLamyRCross-linking with ultraviolet-a and riboflavin reduces corneal permeabilityInvest Ophthalmol Vis Sci201152129275927822064989
   PubMedGoogle Scholar
• LiJLiZZhouTPositively charged micelles based on a triblock copolymer demonstrate enhanced corneal penetrationInt J Nanomedicine2015106027603726451109
   PubMed Web of Science ®Google Scholar
• BaranowskiPKarolewiczBGajdaMOphthalmic drug dosage forms: characterisation and research methodsScientific World Journal2014201486190424772038
   PubMed Web of Science ®Google Scholar
• GuptaHAqilMKharRKAliABhatnagarAMittalGSparfloxacin-loaded PLGA nanoparticles for sustained ocular drug deliveryNanomedicine20106232433319857606
   PubMed Web of Science ®Google Scholar
• LiuXZhangZJiangYNovel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluationDrug Deliv201522222322924559497
   PubMed Web of Science ®Google Scholar
• SukJSXuQKimNHanesJEnsignLMPEGylation as a strategy for improving nanoparticle-based drug and gene deliveryAdv Drug Deliv Rev201699pt A285126456916
   PubMed Web of Science ®Google Scholar
• KalamMADevelopment of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasoneInt J Biol Macromol20168912713627126165
   PubMed Web of Science ®Google Scholar
• AndradeLMRochaKADe SaFAVoriconazole-loaded nanostructured lipid carriers for ocular drug deliveryCornea201635686687127055213
   PubMed Web of Science ®Google Scholar
• LiuRWangSFangSLiquid crystalline nanoparticles as an ophthalmic delivery system for tetrandrine: development, characterization, and in vitro and in vivo evaluationNanoscale Res Lett201611125427188974
   PubMedGoogle Scholar
• AchouriDSergentMTonettoAPiccerellePAndrieuVHornebecqVSelf-assembled liquid crystalline nanoparticles as an ophthalmic drug delivery system. Part II: optimization of formulation variables using experimental designDrug Dev Ind Pharm201541349350124520866
   PubMed Web of Science ®Google Scholar
• ZhangWWangYLeeBTLiuCWeiGLuWA novel nanoscale-dispersed eye ointment for the treatment of dry eye diseaseNanotechnology2014251212510124571862
   PubMed Web of Science ®Google Scholar
• AmriteACKompellaUBSize-dependent disposition of nanoparticles and microparticles following subconjunctival administrationJ Pharm Pharmacol200557121555156316354399
   PubMed Web of Science ®Google Scholar
• Barbault-FoucherSGrefRRussoPGuechotJBochotADesign of poly-epsilon-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular deliveryJ Control Release200283336537512387945
   PubMedGoogle Scholar
• KaurIPKanwarMOcular preparations: the formulation approachDrug Dev Ind Pharm200228547349312098838
   PubMed Web of Science ®Google Scholar
• SasakiHYamamuraKMukaiTEnhancement of ocular drug penetrationCrit Rev Ther Drug Carrier Syst19991618514610099899
   PubMed Web of Science ®Google Scholar
• MotwaniSKChopraSTalegaonkarSKohliKAhmadFJKharRKChitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisationEur J Pharm Biopharm200868351352517983737
   PubMed Web of Science ®Google Scholar
• YingLTaharaKTakeuchiHDrug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: effect of emulsion formulations and surface modificationInt J Pharm2013453232933523796836
   PubMed Web of Science ®Google Scholar
• AttamaAAMuller-GoymannCCInvestigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipidInt J Pharm20073341–217918917140752
   PubMed Web of Science ®Google Scholar